Drug Designing: Open Access : Citations & Metrics Report
Articles published in Drug Designing: Open Access have been cited by esteemed scholars and scientists all around the world. Drug Designing: Open Access has got h-index 9, which means every article in Drug Designing: Open Access has got 9 average citations.
Following are the list of articles that have cited the articles published in Drug Designing: Open Access.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
22 | 32 | 30 | 31 | 67 | 2 | 5 | 16 | 18 | 12 | 14 | 24 | 6 |
Research, Review articles and Editorials |
0 | 2 | 2 | 24 | 33 | 0 | 4 | 15 | 15 | 12 | 10 | 25 | 6 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
14 | 30 | 27 | 7 | 35 | 2 | 1 | 1 | 3 | 0 | 4 | 3 | 0 |
Conference proceedings |
0 | 5 | 5 | 0 | 0 | 0 | 124 | 81 | 41 | 56 | 0 | 0 | 58 |
Citations received as per Google Scholar, other indexing platforms and portals |
45 | 51 | 54 | 62 | 43 | 41 | 41 | 23 | 48 | 16 | 10 | 5 | 0 |
Journal total citations count | 456 |
Journal impact factor | 1.70 |
Journal 5 years impact factor | 1.5 |
Journal cite score | 1.57 |
Journal h-index | 9 |
Journal h-index since 2019 | 7 |
Important citations (297)
Ast dissolving drug delivery system: a review 2015 |
|
Fast dissolving drug delivery system: a review |
|
Transgenic plants: resistance to abiotic and biotic stresses |
|
Nano drug delivery system - a mini review |
|
Potent biological agent benzimidazole–a review |
|
Studies on drug switchability showed heterogeneity in methodological approaches: a scoping review. |
|
On the glycosylation aspects of biosimilarity |
|
Drugs acting on blood coagulation system and theirmechanism of action: a review |
|
Quality assurance & quality control in laboratories: a review |
|
Potential therapeutic targets and the role of technology in developing novel cannabinoid drugs from cyanobacteria. |
|
Stem cell research therapy for neurodegenerative disorders- in what way to make it work |
|
Impaired glucose metabolism in alzheimer's disease and diabetes |
|
Current challenges to overcome in the management of type 2 diabetes mellitus and associated neurological disorders. |
|
Incorporating a monofluoroalkene into the backbones of short peptides: evaluating the impact on local hydrophobicity. |
|
Total quality system breakdowns in outsourced clinical trials |
|
Outsourcing clinical trials outside of the us |
|
The free radical theory of aging matures |
|
Apoe-directed therapeutics rapidly clear ?-amyloid and reverse deficits in ad mouse models. |
|
Mitochondrial diseases in man and mouse |
|
Three structural features of functional food components and herbal medicine with amyloid ?42 anti-aggregation properties. |
|